ProQR Therapeutics N.V. - PRQR

SEC FilingsOur PRQR Tweets

About Gravity Analytica

Recent News

  • 04.30.2026 - ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors
  • 04.08.2026 - ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
  • 04.08.2026 - ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
  • 03.12.2026 - ProQR Announces Year End 2025 Operating and Financial Results

Recent Filings

  • 04.08.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 04.08.2026 - EX-99.1 EX-99.1
  • 04.08.2026 - EX-99.1 EX-99.1
  • 04.08.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 03.25.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 03.25.2026 - EX-99.1 EX-99.1
  • 03.18.2026 - 3 Initial statement of beneficial ownership of securities
  • 03.18.2026 - 3 Initial statement of beneficial ownership of securities
  • 03.18.2026 - 3 Initial statement of beneficial ownership of securities
  • 03.18.2026 - 3 Initial statement of beneficial ownership of securities